Post-metabolic surgery pharmacological adjuvant

Post-metabolic surgery pharmacological adjuvant

Treating type 2 diabetes mellitus (T2DM) in patients with obesity remains a challenge for physicians, endocrinologists and surgeons, a fact supported by uncontroverted evidence from studies looking at mortality and associated morbidity. Metabolic surgery remains the most effective treatment for obes...

Full description

Bibliographic Details
Main Author: Marianela Ackermann
Format: Article
Language:Spanish
Published: Sello Editorial Lugones 2022-09-01
Series:Revista de la Sociedad Argentina de Diabetes
Subjects:
obesidad
diabetes mellitus
Online Access:https://revistasad.com/index.php/diabetes/article/view/614

Similar Items

Similar Items